Daewoong Co Ltd
003090
Company Profile
Business description
Daewoong Co Ltd is a Korea-based holding company engaged in the manufacture of pharmaceuticals. Also, it is engaged in the food processing business, provides enterprise education solutions and information technology business solutions. The Company's products include Nabota, Ursa, Fexuclu, Enblo, Crezet, Olmetec, Gasmotin, and Impactamin.
Contact
244, Galmachi-ro
Jungwon-gu
Seongnam-siGyeonggi-do
KORT: +82 25508800
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
386
Stocks News & Analysis
stocks
Reassuring organic growth for undervalued ASX share
Efficiency gains are starting to make their mark.
stocks
Big IPOs are enticing but are they good investments?
Historically, buzzy debuts have been painful for buyers.
stocks
This defensive ASX listed REIT offers a 5% yield
Solid outlook underpinned by rent uplifts and development pipeline.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,692.80 | 143.80 | -1.63% |
| CAC 40 | 7,972.39 | 108.35 | -1.34% |
| DAX 40 | 24,986.22 | 477.59 | -1.88% |
| Dow JONES (US) | 49,097.06 | 1,101.11 | -2.19% |
| FTSE 100 | 10,391.10 | 61.58 | -0.59% |
| HKSE | 22,410.80 | 430.82 | -1.89% |
| NASDAQ | 23,879.20 | 550.69 | -2.25% |
| Nikkei 225 | 56,436.65 | 3,007.56 | -5.06% |
| NZX 50 Index | 14,107.41 | 139.84 | -0.98% |
| S&P 500 | 7,175.83 | 147.80 | -2.02% |
| S&P/ASX 200 | 8,592.60 | 137.80 | -1.58% |
| SSE Composite Index | 3,533.79 | 43.82 | -1.22% |